SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vineet Laboratories informs about trading window closure

30 Dec 2022 Evaluate
Vineet Laboratories has informed that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 read with the Company's Code of Conduct for regulate, monitor and report trading by Insiders and Code of Practices and Procedures for fair disclosure of Unpublished Price Sensitive Information, the Trading Window for dealing in the securities of the Company will remain closed from 01st January 2023 till 48 hours after the announcement of unaudited financial results for the third quarter & nine months ended 31st December 2022 for all designated persons, their immediate relatives and all connected persons covered under the said Code.

The above information is a part of company’s filings submitted to BSE.

Vineet Laboratories Share Price

34.89 1.64 (4.93%)
16-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.65
Dr. Reddys Lab 1277.05
Cipla 1372.75
Zydus Lifesciences 1078.40
Lupin 2277.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: